Bio-plastics production grows to 7.5 milli...The market for bio-based building blocks and polymers showed moderate growth to 7.5 million tonnes in 2018 and will grow with a CGAR of 4% by 2023 reports German nova-Institute. more ➔
Reprogrammed pancreatic cells cure type I...Swiss researchers have demonstrated a way to cure type I diabetes without cell transplantation. In model mice the reprogrammed non-islet cells from human pancreas more ➔
Afyren raises €21m to launch production...French industrial biotech company Afyren announced a capital increase of €21m in a financing round led by Sofinnova Partners and Valquest Partners to scale up its biobased organic acid production … more ➔
Industrial biotech hub validates start-up...Biotech Campus Delft, Royal DSM and YES!Delft partner up have launched a Biotech Validation Lab to validate the business concepts of European biotech startups. more ➔
uniqure delivers POC for hemophilia B gene...Gene therapy uniQure NV (Amsterdam) reported that factor IX levels of patients with severe hemophilia B raised to a mean of 38% of normal 12 weeks after a single injection of AMT-061. more ➔
Ose Pharma gets clinical milestone for IL7...Ose Immunotherapeutics has got the first milestone payment within its €272m deal with Servier inked in 2016. more ➔
How stroma cells trigger tumour angiogenes...Analyses of the stroma cell proteome have revealed how intratumoral hypoxia triggers the formation of dysfunctional blood vessels that block drugs from entering the tumour and push metastasis. … more ➔
Jennewein Biotechnologie expands into Chin...Jennewein Biotechnologie and Asia’s largest dairy company Yili Group have joined forces to develop an innovative infant formula tailored to the Chinese market. more ➔
Medicxi put €40m into two Sosei spin off...Sosei Group Corporation has spun out two programmes of its neurology pipeline into two newly created companies funded by venture fund Medicxi. more ➔
EMA greenlights two orphan drugs and two b...EMAs human medicines committee (CHMP) recommended six medicines for approval at its January 2019 meeting. more ➔
